Advertisement

Vitamin C pp 107-123 | Cite as

Recommended Vitamin C Intake: From Molecular Mechanisms to Clinical Application

  • M. Levine
  • S. C. Rumsey
  • Y. Wang
  • J. Park
  • R. Daruwala
  • N. Amano
Conference paper

Abstract

The current recommended dietary allowance in the United States (U.S. RDA) for vitamin C (ascorbate) is 60 mg daily [1, 2]. Similar or lower values are used in other countries throughout the world except France, where the value is 80 mg daily. The U.S. RDA is based on prevention of clinical vitamin C deficiency, or scurvy, with a margin of safety. Safety is arbitrarily defined as prevention of scurvy for 1 month if vitamin C ingestion were to cease. Adequate vitamin C stores are also believed to occur at the dose which is at the threshold of urinary excretion of vitamin.

Keywords

High Pressure Liquid Chromatography Recommended Dietary Allowance Dehydroascorbic Acid Chromaffin Granule Ascorbate Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Food and Nutrition Board (1980) Vitamin C (ascorbic acid). In: Committee on Dietary Allowances (ed) Recommended dietary allowances, 9th edn. National Academy of Sciences, Washington, DC, pp 72–81Google Scholar
  2. 2.
    Food and Nutrition Board (1989) Recommended Dietary Allowances, 10th edn. National Academy Press, Washington, DC, pp 115–124Google Scholar
  3. 3.
    Baker EM, Hodges RE, Hood J, Sauberlich HE, March SC (1969) Metabolism of ascorbic-1–14C acid in experimental human scurvy. Am J Clin Nutr 22:549–558PubMedGoogle Scholar
  4. 4.
    Hodges RE, Baker EM, Hood J, Sauberlich HE, March SC (1969) Experimental scurvy in man. Am J Clin Nutr 22:535–548PubMedGoogle Scholar
  5. 5.
    Baker EM, Hodges RE, Hood J, Sauberlich HE, March SC, Canham JE (1971) Metabolism of 14C- and 3H-labeled L-ascorbic acid in human scurvy. Am J Clin Nutr 24:444–454PubMedGoogle Scholar
  6. 6.
    Hodges RE, Hood J, Canham JE, Sauberlich HE, Baker EM (1971) Clinical manifestations of ascorbic acid deficiency in man. Am J Clin Nutr 24:432–443PubMedGoogle Scholar
  7. 7.
    Hodges RE (1971) What’s new about scurvy? Am J Clin Nutr 24:383–384PubMedGoogle Scholar
  8. 8.
    Food and Nutrition Board (1994) How should the Recommended Dietary Allowances be revised. National Academy Press, Washington, DC, pp 1–24Google Scholar
  9. 9.
    Levine M, Rumsey S, Wang Y, Park JB, Kwon O, Amano N (1997) In situ kinetics: an approach to recommended intake of vitamin C. In: McCormick DB, Suttie JW, Wagner C (eds) Methods in enzymology. Academic, San Diego, pp 425–437Google Scholar
  10. 10.
    Levine M, Rumsey S, Wang Y (1997) Principles involved in formulating recommendations for vitamin C intake: a paradigm for water soluble vitamins. In: McCormick DB, Suttie JW, Wagner C (eds) Vitamins and coenzymes. Academic, San Diego, pp 43–54Google Scholar
  11. 11.
    Levine M (1986) New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med 314:892–902PubMedCrossRefGoogle Scholar
  12. 12.
    Levine M, Dhariwal KR, Welch RW, Wang Y, Park JB (1995) Determination of optimal vitamin C requirements in humans. Am J Clin Nutr 62[Suppl]:1347S–1356SPubMedGoogle Scholar
  13. 13.
    Levine M, Rumsey S, Wang Y, Park JB, Kwon O, Xu W, Amano N (1996) Vitamin C. In: Filer LJ, Ziegler EE (eds) Present knowledge in nutrition, 7th edn. International Life Sciences Institute, Washington, DC, pp 146–159Google Scholar
  14. 14.
    Levine M, Dhariwal KR, Washko PW, Butler JD, Welch RW, Wang YH, Bergsten P (1991) Ascorbic acid and in situ kinetics: a new approach to vitamin requirements. Am J Clin Nutr 54:1157S–1162SPubMedGoogle Scholar
  15. 15.
    Kaufman S (1974) Dopamine-beta-hydroxylase. J Psychiatr Res 11:303–316PubMedCrossRefGoogle Scholar
  16. 16.
    Dhariwal KR, Black CD, Levine M (1991) Semidehydroascorbic acid as an intermediate in norepinephrine biosynthesis in chromaffin granules. J Biol Chem 266:12908–12914PubMedGoogle Scholar
  17. 17.
    Fleming PJ, Kent UM (1991) Cytochrome b561, ascorbic acid, and transmembrane electron transfer. Am J Clin Nutr 54:1173S–1178SPubMedGoogle Scholar
  18. 18.
    Dhariwal KR, Washko P, Hartzell WO, Levine M (1989) Ascorbic acid within chromaffin granules. In situ kinetics of norepinephrine biosynthesis. J Biol Chem 264:15404–15409PubMedGoogle Scholar
  19. 19.
    Dhariwal KR, Shirvan M, Levine M (1991) Ascorbic acid regeneration in chromaffin granules. In situ kinetics. J Biol Chem 266:5384–5387PubMedGoogle Scholar
  20. 20.
    Washko PW, Welch RW, Dhariwal KR, Wang Y, Levine M (1992) Ascorbic acid and dehydroascorbic acid analyses in biological samples. Anal Biochem 204:1–14PubMedCrossRefGoogle Scholar
  21. 21.
    Ronchetti IP, Quaglino DJ, Bergamini G (1996) Ascorbic acid and connective tissue. In: Harris JR (ed) Ascorbic acid: biochemistry and biomedical cell biology. Plenum, New York, pp 249–262Google Scholar
  22. 22.
    Jialal I, Vega GL, Grundy SM (1990) Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 82:185–191PubMedCrossRefGoogle Scholar
  23. 23.
    Diaz MN, Frei B, Vita JA, Keaney JFJ (1997) Mechanisms of disease: antioxidants and atherosclerotic heart disease. N Engl J Med 337:408–416PubMedCrossRefGoogle Scholar
  24. 24.
    Welch RW, Bergsten P, Butler JD, Levine M (1993) Ascorbic acid accumulation and transport in human fibroblasts. Biochem J 294:505–510PubMedGoogle Scholar
  25. 25.
    Bergsten P, Yu R, Kehrl J, Levine M (1995) Ascorbic acid transport and distribution in human B lymphocytes. Arch Biochem Biophys 317:208–214PubMedCrossRefGoogle Scholar
  26. 26.
    Levine M, Cantilena CC, Dhariwal KR (1993) In situ kinetics and ascorbic acid requirements. World Rev Nutr Diet 72:114–127PubMedGoogle Scholar
  27. 27.
    Jacob RA, Skala JH, Omaye ST (1987) Biochemical indices of human vitamin C status. Am J Clin Nutr 46:818–826PubMedGoogle Scholar
  28. 28.
    Kallner A, Hartmann D, Hornig D (1979) Steady-state turnover and body pool of ascorbic acid in man. Am J Clin Nutr 32:530–539PubMedGoogle Scholar
  29. 29.
    VanderJagt DJ, Garry PJ, Bhagavan HN (1987) Ascorbic acid intake and plasma levels in healthy elderly people. Am J Clin Nutr 46:290–294PubMedGoogle Scholar
  30. 30.
    Garry PJ, Vanderjagt DJ, Hunt WC (1987) Ascorbic acid intakes and plasma levels in healthy elderly. Ann N Y Acad Sci 498:90–99PubMedCrossRefGoogle Scholar
  31. 31.
    Blanchard J (1991) Depletion and repletion kinetics of vitamin C in humans. J Nutr 121:170–176PubMedGoogle Scholar
  32. 32.
    Hegsted DM (1992) Defining a nutritious diet: need for new dietary standards. J Am Coll Nutr 11:241–245PubMedGoogle Scholar
  33. 33.
    King J, Wang Y, Welch RW, Dhariwal KR, Conry-Cantilena C, Levine M (1997) Utilization of a new vitamin C deficient diet in a depletion-repletion clinical trial. Am J Clin Nutr 65:1434–1440PubMedGoogle Scholar
  34. 34.
    Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich J, King J, Cantilena LR (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a Recommended Dietary Allowance. Proc Natl Acad Sci USA 93:3704–3709PubMedCrossRefGoogle Scholar
  35. 35.
    Jacob RA, Pianalto FS, Agee RE (1992) Cellular ascorbate depletion in healthy men. J Nutr 122:1111–1118PubMedGoogle Scholar
  36. 36.
    Rowland M, Tozer TN (1989) Clinical pharmacokinetics: concepts and applications. Lea and Febiger, Philadelphia, pp 459–461Google Scholar
  37. 37.
    Graumlich J, Ludden TM, Conry-Cantilena C, Cantilena LR, Wang Y, Levine M (1997) Pharmacokinetic model of ascorbic acid in humans during depletion and repletion. Pharmaceut Res 14:1133–1139CrossRefGoogle Scholar
  38. 38.
    Koplan JP, Annest JL, Layde PM, Rubin GL (1986) Nutrient intake and supplementation in the United States (NHANES II). Am J Public Health 76:287–290PubMedCrossRefGoogle Scholar
  39. 39.
    Murphy SP, Rose D, Hudes M, Viteri FE (1992) Demographic and economic factors associated with dietary quality for adults in the 1987–88 Nationwide Food Consumption Survey. J Am Diet Assoc 92:1352–1357PubMedGoogle Scholar
  40. 40.
    Life Sciences Research Office, Interagency Board for Nutrition Monitoring and Related Research (1995) Third report on nutrition monitoring in the United States. US Government Printing Office, Washington, DC, pp ES-14-ES-29Google Scholar
  41. 41.
    Urivetzky M, Kessaris D, Smith AD (1992) Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol 147:1215–1218PubMedGoogle Scholar
  42. 42.
    Byers T, Guerrero N (1995) Epidemiologic evidence for vitamin C and vitamin E in cancer prevention. Am J Clin Nutr 62:1385S–1392SGoogle Scholar
  43. 43.
    Ramirez J, Flowers NC (1980) Leukocyte ascorbic acid and its relationship to coronary artery disease in man. Am J Clin Nutr 33:2079–2087PubMedGoogle Scholar
  44. 44.
    Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450–1456PubMedCrossRefGoogle Scholar
  45. 45.
    Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group [published erratum appears in JAMA 1995 Feb 22;273(8):622].Google Scholar
  46. 45.
    Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 272:1413–1420Google Scholar
  47. 46.
    Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF (1991) Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 337:1–5PubMedCrossRefGoogle Scholar
  48. 47.
    Jacques PF, Chylack LT Jr, McGandy RB, Hartz SC (1988) Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 106:337–340PubMedCrossRefGoogle Scholar
  49. 48.
    Leske MC, Chylack LT, Wu S (1991) The lens opacities case/control study: risk factors for cataract. Arch Opthalmol 109:244–251CrossRefGoogle Scholar
  50. 49.
    Vitale S, West S, Hallfrisch J, Alston C, Wang F, Moorman C, Muller D, Singh V, Taylor HR (1993) Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 4:195–203PubMedCrossRefGoogle Scholar
  51. 50.
    Hankinson SE, Stampfer MJ, Seddon JM, Colditz GA, Rosner B, Speizer FE, Willett WC (1992) Nutrient intake and cataract extraction in women: a prospective study. BMJ 305:335–339PubMedCrossRefGoogle Scholar
  52. 51.
    Enstrom JE, Kanim LE, Klein MA (1992) Vitamin C intake and mortality among a sample of the United States population. Epidemiology 3:194–202PubMedCrossRefGoogle Scholar
  53. 52.
    Enstrom JE, Kanim LE, Breslow L (1986) The relationship between vitamin C intake, general health practices, and mortality in Alameda County, California. Am J Public Health 76:1124–1130PubMedCrossRefGoogle Scholar
  54. 53.
    Gey KF, Stahelin HB, Eichholzer M (1993) Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Invest 71:3–6CrossRefGoogle Scholar
  55. 54.
    Washko PW, Wang Y, Levine M (1993) Ascorbic acid recycling in human neutrophils. J Biol Chem 268:15531–15535PubMedGoogle Scholar
  56. 55.
    Welch RW, Wang Y, Crossman A Jr, Park JB, Kirk KL, Levine M (1995) Accumulation of vitamin C (ascorbate) and its oxidized metabolite dehydroascorbic acid occurs by separate mechanisms. J Biol Chem 270:12584–12592PubMedCrossRefGoogle Scholar
  57. 56.
    Park JB, Levine M (1996) Purification, cloning, and expression of dehydroascorbic acid reduction activity from human neutrophils: identification as glutaredoxin. Biochem J 315:931–938PubMedGoogle Scholar
  58. 57.
    Rumsey SC, Kwon O, Xu G, Burant CF, Simpson I, Levine M (1997) Glucose transporter isoforms GLUTI and GLUT3 transport dehydroascorbic acid. J Biol Chem 272:18982–18989PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1998

Authors and Affiliations

  • M. Levine
    • 1
  • S. C. Rumsey
    • 1
  • Y. Wang
    • 1
  • J. Park
    • 1
  • R. Daruwala
    • 1
  • N. Amano
    • 1
  1. 1.Molecular and Clinical Nutrition Section, National Institute of Diabetes and Digestive and Kidney DiseasesNational Institutes of HealthBethesdaUSA

Personalised recommendations